Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis

Publisher： Karger

E-ISSN： 1423-0232|87|2|95-103

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.2, 2014-07, pp. : 95-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alveolar Soft Part Sarcoma in Japan: Multi-Institutional Study of 57 Patients from the Japanese Musculoskeletal Oncology Group

By  

Oncology, Vol. 65, Iss. 1, 2003-07 ,pp. : 7-13

Karger

Access to resources Recommend Favorite

Cancer multidisciplinary team meetings in practice: Results from a multi‐institutional quantitative survey and implications for policy change

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 74-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retrospective Analysis of the Efficacy of Gemcitabine for Previously Treated AIDS-Associated Kaposi’s Sarcoma in Western Kenya

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 5-11

Karger

Access to resources Recommend Favorite

Complications and Short-Term Explantation Rate Following Artificial Urinary Sphincter Implantation: Results from a Large Middle European Multi-Institutional Case Series

By  

Urologia Internationalis, Vol. 97, Iss. 2, 2016-06 ,pp. : 205-211

Karger

Access to resources Recommend Favorite

Docetaxel and Gemcitabine in the Treatment of Soft Tissue Sarcoma – A Single-Center Experience

By  

Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. : 11-16

Karger

Access to resources Recommend Favorite